The Joint Corp.

NASDAQ:JYNT

Medical - Care Facilities

Healthcare
$6.65 +1.86%

+$0.17 today

Market cap
$91.03M
Beta
1.10
P/E (TTM)
40.7
EPS (TTM)
$0.23
52W Low $7.50High $13.00

Volume 0.05M

Average 0.07M

JYNT Deferred Revenue (Non-current)

Payments received for goods or services the company will deliver after more than one year.

The Joint Corp.NASDAQ: JYNT

Deferred Revenue (Non-current) · Q1 FY2026 · quarter ended Mar 2026

Deferred revenue (non-current) falls 14.5% from a year ago

Deferred revenue (non-current) stood at $10.21M at the end of Q1 FY2026, down 14.5% from a year earlier and down 6.3% from the prior quarter. Over 3 fiscal years it compounded at -8.4% a year.

Context

  • Deferred revenue (non-current) amounted to 17.6% of total assets at the end of Q1 FY2026, up 2.2 pp from a year earlier.
  • Deferred revenue (non-current) increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether deferred revenue (non-current) keeps falling in the next quarterly balance sheet after a -14.5% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$10.21M-6.3% QoQ
Last fiscal yearDec 2025
$10.9M-12.5% YoY
Year agoMar 2025
$11.94M-14.5% since
Deferred Revenue (Non-current) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-14.5%——
1 year-12.5%——
3-year CAGR-8.4%——
5-year CAGR——
10-year CAGR——

Deferred Revenue (Non-current) history

USD · from the balance sheet

Latest · FY2025
10.9M USD
Year-over-year change
-12.5%
4-year CAGR
-4.2%

Deferred Revenue (Non-current) vs competitors

How JYNT compares with its peers on the latest reported figures

  • JYNT's Mar 2026 deferred revenue (non-current) of $10.21M is the highest of the 11 companies compared; the peer median is $0.
  • Its year-over-year change of -14.5% is the 3rd highest of 4, against a peer median of -5.3%.
  • Deferred revenue (non-current) amounts to 17.6% of total assets for JYNT, versus a peer median of 0.0%.
JYNT Competitors Peer median
Deferred Revenue (Non-current) for JYNT and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
JYNTThe Joint Corp.Mar 2026$10.21M -14.5%-8.4%17.6%
APYXApyx Medical CorporationMar 2026$1.13M -5.3%-9.3%1.8%
BTMDbiote Corp.Mar 2026$922K -36.4%+5.8%1.0%
CCLDCareCloud, Inc.Mar 2026$891K +56.0%+33.2%1.0%
IKTInhibikase Therapeutics, Inc.Mar 2026$0 ——0.0%
LUCDLucid Diagnostics Inc.Mar 2026$0 ——0.0%
SERASera Prognostics, Inc.Mar 2026$0 ——0.0%
CGTXCognition Therapeutics, Inc.Mar 2026$0 ——0.0%
STSSSkyAI, Inc.Mar 2026$0 ——0.0%
RPIDRapid Micro Biosystems, Inc.Mar 2026$0 ——0.0%
DCGODocGo Inc.Mar 2026$0 ——0.0%
Peer median (excluding JYNT) $0-5.3%+5.8%0.0%

Competitors are the stored peer set for JYNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents19.53M9.75M18.15M25.05M23.6M
Short-term Investments00000
Net Receivables3.7M3.91M2.58M2.59M2.85M
Inventory00000
Other Current Assets1.38M3.96M23.6M46.94M25.64M
Total Current Assets26.89M17.61M44.34M74.58M52.09M
Property, Plant & Equipment (Net)32.81M38.06M4.27M3.76M4.73M
Goodwill5.09M8.49M7.35M00
Intangible Assets4.71M10.93M5.02M00
Long-term Investments00000
Tax Assets11.49M11.93M1.03M00
Other Non-current Assets6.07M6.46M25.19M4.81M4.15M
Total Non-current Assets60.17M75.88M42.87M8.58M8.88M
Total Assets87.06M93.49M87.21M83.15M60.97M
Account Payables1.71M2.97M1.25M1.75M1.59M
Short-term Debt00000
Tax Payables00000
Deferred Revenue8.43M10.43M2.52M2.55M2.8M
Other Current Liabilities925.72K1.4M27.37M39.2M22.68M
Total Current Liabilities21.44M23.22M33.57M49.04M32.82M
Long-term Debt2M2M2M00
Deferred Tax Liabilities0057.15K00
Deferred Revenue (Non-current)12.95M14.16M13.6M12.45M10.9M
Other Non-current Liabilities3.4M2.79M12.76M672.33K355.56K
Total Non-current Liabilities35.31M37.69M28.86M13.43M13.07M
Total Liabilities56.75M60.9M62.44M62.48M45.89M
Common Stock14.45K14.56K14.78K15.19K15.47K
Retained Earnings(12.78M)(12.15M)(21.91M)(27.7M)(24.8M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest25K25K25K25K25K
Total Equity30.31M32.59M24.77M20.68M15.08M
Total Debt23.62M26.06M2.86M795.03K2.01M
Net Debt4.1M16.31M(15.29M)(24.26M)(21.59M)

The Joint Corp.

NASDAQ:JYNT

Intrinsic Alpha fair value

Locked

Current Price

$6.65

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.